Introduction
This information leaflet is for patients who have been advised to take SGLT-2 inhibitors to treat their type 2 diabetes and/or to protect their kidneys and heart. It provides information on the different medication, possible side effects and when you should stop taking the medication.
What are SGLT-2 inhibitors?
SGLT-2 inhibitors ('SGLT-2i', also known as ‘gliflozins’) are a class of drugs used in the treatment of diabetes, heart failure and chronic kidney disease. The drugs include dapagliflozin (Forxiga®), empagliflozin (Jardiance®), canagliflozin (Invokana®) and ertugliflozin (Steglatro®).
These medicines were originally developed to lower blood glucose (sugar) levels in people with type 2 diabetes. They lower blood glucose by increasing the amount of glucose passed out of the body in the urine.
These medicines have now been shown to have added benefits that include protecting the kidneys and heart. They can slow the decline in kidney function and reduce the risk of heart failure and heart attacks in individuals at most risk. These kidney and heart benefits apply to all individuals, not just those with diabetes.
If you are prescribed an SGLT-2i and have other medical problems, you might be asked to have extra blood pressure measurements taken. The doctor prescribing the SGLT-2i will advise if this is necessary for you.
Non-urgent advice: When should I stop taking my SGLT-2 inhibitor (gliflozin)?
SGLT-2i should be temporarily stopped if you become unwell
To keep safe whilst using SGLT-2i, we recommend following some simple instructions called 'Sick Day Rules' if you become unwell, particularly with vomiting, diarrhoea and fever.
Sick Day Rules
- You should temporarily stop these medications, if unwell, especially if you are experiencing vomiting, diarrhoea or fever.
- Stay hydrated and keep drinking fluids (try taking regular small sips).
- Do not fast (starve). Maintain carbohydrate intake (starchy food).
- Seek medical advice if you cannot keep fluids down or if you have been told to limit the amount of fluid you can drink (particularly for heart failure patients).
- Seek urgent medical attention as above so that DKA can be excluded as the cause.
- Tell the doctor you are taking an SGLT-2 inhibitor (gliflozin), so they can ensure you have the correct tests, in particular, excluding DKA.
SGLT-2i should be temporarily stopped if you are told to fast (starve)
You should stop taking SGLT-2i at least one day before fasting for surgery or a procedure. SGLT-2i can be restarted once you are stable post-surgery and you are eating and drinking normally.
Foot care
It is important to check your feet regularly. If you have an active infection in the foot, and/or are likely to require surgery on your foot, your diabetes team may recommend that you should temporarily stop these medications.
Pregnancy and breastfeeding
Do not use these tablets if you are:
- pregnant
- breastfeeding
- sexually active but not using contraception (and so could potentially become pregnant)
Please read the patient information leaflet that comes with the tablets for further information.
We are smoke-free
Smoking is not allowed anywhere on the hospital campus. For advice and support in quitting, contact your GP or the free NHS stop smoking helpline on 0800 169 0 169.
Other formats
Help accessing this information in other formats is available. To find out more about the services we provide, please visit our patient information help page (see link below) or telephone 01223 256998. www.cuh.nhs.uk/contact-us/accessible-information/
Contact us
Cambridge University Hospitals
NHS Foundation Trust
Hills Road, Cambridge
CB2 0QQ
Telephone +44 (0)1223 245151
https://www.cuh.nhs.uk/contact-us/contact-enquiries/